Complete ICD-10-CM coding and documentation guide for Non-Hodgkin Lymphoma. Includes clinical validation requirements, documentation requirements, and coding pitfalls.
Also known as:
Complete code families applicable to Non-Hodgkin Lymphoma
Non-Hodgkin Lymphomas
This range includes all specific types of Non-Hodgkin Lymphomas, covering various subtypes and grades.
Compare key differences between these codes to ensure accurate selection
Code | Description | When to Use | Key Documentation |
---|---|---|---|
C85.90 | Non-Hodgkin lymphoma, unspecified | Use when the specific subtype of NHL is not documented. |
|
C83.30 | Diffuse large B-cell lymphoma, unspecified site | Use for active DLBCL when the site is not specified. |
|
C83.3A | Diffuse large B-cell lymphoma in remission | Use when DLBCL is in remission. |
|
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Essential facts and insights about Non-Hodgkin Lymphoma
Use for active DLBCL when the site is not specified.
Ensure active disease status is documented.
Use when DLBCL is in remission.
Ensure remission is clearly documented.
Alternative codes to consider when ruling out similar conditions to the primary diagnosis.
Avoid these common documentation and coding issues when documenting Non-Hodgkin Lymphoma to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code C85.90.
Clinical: May lead to inappropriate treatment planning., Regulatory: Non-compliance with documentation standards., Financial: Potential for incorrect billing.
Always specify if the disease is active or in remission., Use appropriate history codes when applicable.
Reimbursement: May lead to lower reimbursement rates., Compliance: Non-compliance with coding guidelines., Data Quality: Decreases the accuracy of patient records.
Always document and code the specific subtype of NHL.
Failure to document remission status accurately.
Implement regular audits of oncology documentation.
Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.
Common questions about ICD-10 coding for Non-Hodgkin Lymphoma, with expert answers to help guide accurate code selection and documentation.
Use these documentation templates to ensure complete and accurate documentation for Non-Hodgkin Lymphoma. These templates include all required elements for proper coding and billing.
Need help with ICD-10 coding for Non-Hodgkin Lymphoma? Ask your questions below.